NEW BRUNSWICK, N.J. – Get ready, investors. JNJ, the healthcare behemoth, is set to unveil its second-quarter results. Mark your calendars: Chairman and CEO Joaquin Duato, along with CFO Joseph J. Wolk and Vice President of Investor Relations Darren Snellgrove, will be taking the virtual stage at 8:30 a.m. Eastern Time on Wednesday, July 16th.
This call is anticipated to be a deep dive into the company’s performance, offering invaluable insights into the current healthcare landscape and the strategies driving Johnson & Johnson’s continued evolution. The usual suspects in the executive team will likely be on hand to answer any questions investors may have.
Here’s how you can tune in to the action, whether you’re an institutional investor or a casual observer:**
- The primary source will be Johnson & Johnson’s website, located at www.investor.jnj.com. The presentation material will be available there, alongside the webcast. And for those who are unable to join live, a replay will be available approximately three hours after the call concludes.
- For those preferring the old-school charm of a phone call, dial-in numbers for the U.S. are 877-869-3847. For international participants, the dial-in is 201-689-8261.
- If you miss the initial broadcast, the replay of the conference call will be available until approximately 12:00 a.m. on July 30th. US participants can dial 877-660-6853, while international callers should dial 201-612-7415. The replay conference ID is 13754017.
- The full press release will be available at about 6:45 a.m. Eastern Time on the morning of the call.
- Interested in planning ahead? The company has already set Tuesday, October 14th, 2025 as their tentative date for their third-quarter earnings call.
About Johnson & Johnson
Johnson & Johnson’s mission is to build a healthier world. The Company focuses on healthcare innovation, developing and commercializing treatments that deliver breakthroughs for patients to make a positive impact on health for humanity. You can find out more at https://www.jnj.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250528972988/en/
Source: Johnson & Johnson
Original article, Author: Jam. If you wish to reprint this article, please indicate the source:https://aicnbc.com/1175.html
